About Surien Pharmaceuticals Private Limited
Data last updated:
Surien Pharmaceuticals Private Limited is a private limited company based in Chennai, Tamil Nadu, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 April 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Chennai, under CIN U24232TN2004PTC053031. Its GSTIN is 33AAICS6002K1ZG (Tamil Nadu).
The company has an authorised share capital of ₹5 Cr and a paid-up capital of ₹2.16 Cr. It was formerly known as Shince Pharmaceuticals Private Limited. It is led by directors including Ramasamy Krishnamoorthy (Managing Director) and Chathurappan Anbazhagan (Whole-Time Director).
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 108 Chekkadi Street Kovur, Chennai, Tamil Nadu, India – 602101.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.68 Cr, a decline of 18% compared to the previous year. For the same year it recorded a net profit of ₹7.33 Lakh (net margin 0.4%) and EBITDA of ₹1.59 Cr (EBITDA margin 9.5%). Revenue has declined at a compounded annual rate (CAGR) of 27% over three years and 10% over five years.
The company is associated with 1 brand: Surien Pharmaceuticals. As per MCA filings, the company has open charges of ₹20.21 Cr and satisfied charges of ₹6.06 Cr on record. Court records list 52 cases involving the company, including 52 filed against it; 6 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website surienpharmaceuticals.com.
Company details
Contact details
Surien Pharmaceuticals Private Limited's registered office is in Chennai, Tamil Nadu. Its website is surienpharmaceuticals.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address108 Chekkadi Street Kovur, Chennai, Tamil Nadu, India – 602101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Surien Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Surien Pharmaceuticals operates one associated brand: Surien Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures tablets, capsules, syrups and exports pharmaceutical products globally. | surienpharma.in |
Business activity
The main business activity of Surien Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Surien Pharmaceuticals Private Limited, buy the company report.
Financials of Surien Pharmaceuticals Private Limited
FY 2024 filings availableSurien Pharmaceuticals Private Limited reported revenue of ₹16.68 Cr (down 18% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 18% fall in the latest year. EBITDA rose 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.59 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹7.33 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.5% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Surien Pharmaceuticals Private Limited, buy the company report.
Board of directors of Surien Pharmaceuticals Private Limited
Surien Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Gowri Krishnamoorthy | Director | 21 Apr 2004 | 22 Years 6 Months | Current |
| Ramasamy Krishnamoorthy | Managing Director | 21 Apr 2007 | 19 Years 6 Months | Current |
| Chathurappan Anbazhagan | Whole-Time Director | 11 Oct 2018 | 8 Years 0 Months | Current |
Peer comparison
Surien Pharmaceuticals Private Limited is compared with the 6 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Leiutis Pharmaceuticals Private Limited | ₹16.75 Cr (FY 2020) | 62.0% | Hyderabad, Telangana, India | |||
| Salius Pharma Private Limited | ₹16.74 Cr (FY 2025) | 17.0% | Thane, Maharashtra, India | |||
| Merlin Pharma Private Limited | ₹16.74 Cr (FY 2024) | 24.0% | Mumbai, Maharashtra, India | |||
| Surien Pharmaceuticals Private Limitedthis company | ₹16.68 Cr (FY 2025) | ₹7.33 Lakh | 0.4% | -18.0% | Chennai, Tamil Nadu, India | |
| Oasis Laboratories Pvt Ltd | ₹16.68 Cr (FY 2025) | -1.0% | Jaipur, Rajasthan, India | |||
| Regal Healthcare Limited | ₹16.64 Cr (FY 2025) | -15.0% | Vadodara, Gujarat, India | |||
| Cortex Laboratories Private Limited | ₹16.61 Cr (FY 2025) | 44.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Surien Pharmaceuticals Private Limited, buy the company report.
Auditor
Surien Pharmaceuticals Private Limited is audited by N.R.KRISHNAMOORTHY & CO for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| N.R.KRISHNAMOORTHY & CO | FY 2024 | 001492S |
Shareholding
The shareholding of Surien Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Surien Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 02 Dec 2023 | 100828083 | Others | ₹52 Lakh | Open | |
| 22 Sep 2022 | 100615448 | Others | ₹10.77 Cr | Open | |
| 04 Sep 2010 | 10294826 | State Bank of India | ₹8.92 Cr | Open | |
| 31 Oct 2016 | 100085163 | Others | ₹1 Cr | Satisfied | |
| 10 Jan 2009 | 10145636 | Karnataka Bank Limited | ₹1 Cr | Satisfied |
To see the full charge records of Surien Pharmaceuticals Private Limited, buy the company report.
Total charge records: 8 View all charges
Legal cases
Surien Pharmaceuticals Private Limited has 52 court cases on record: 52 filed against it. 6 cases are pending and 46 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 45 | 45 | 4 |
| High courts | 7 | 7 | 2 |
Cases on record (5 of 52)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chennai, Tamil Nadu | Court case (COS) | Filed against the company by M E C International Private Ltd | Pending |
| District court, Puducherry | Criminal case | Filed against the company by Swashthik Plascon Limited Represented by Its Authorized Signatory Mr Vengadesan | Pending |
| Bombay High Court | Court case (COMIP) | Filed against the company by Sun Pharmaceutical Industries Ltd and 2 others | Pending |
| High Court | Court case (COMIP) | Filed against the company by Centaur Pharmaceuticals Private Limited | Pending |
| Bombay High Court | Interim or miscellaneous application | Filed against the company by Sun Pharmaceutical Industries Ltd and 2 others | Disposed |
To see the full case history of Surien Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Credit ratings & regulatory alerts
Surien Pharmaceuticals Private Limited was last rated by Brickwork on 04 Aug 2021.
| Rating agency | Rated on | Rating |
|---|---|---|
| Brickwork | 04 Aug 2021 |
To see the full credit ratings and regulatory alerts of Surien Pharmaceuticals Private Limited, buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Surien Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Surien Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 33AAICS6002K1ZG | Tamil Nadu | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Surien Pharmaceuticals Private Limited, buy the company report.
Recent activity
Surien Pharmaceuticals Private Limited has 4 board changes on record since 2004: 3 appointments and 1 cessation. The latest: Chathurappan Anbazhagan was appointed as Whole-Time Director on 11 Oct 2018.
9 earlier events are in the company report.
Frequently asked questions
Surien Pharmaceuticals is an active private limited company based in Chennai, Tamil Nadu, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 April 2004 (22+ years old) and is registered under CIN U24232TN2004PTC053031.
Surien Pharmaceuticals has 3 current directors:
- Ramasamy Krishnamoorthy - Managing Director
- Chathurappan Anbazhagan - Whole-Time Director
- Gowri Krishnamoorthy - Director
The latest financial statements of Surien Pharmaceuticals on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Surien Pharmaceuticals is 33AAICS6002K1ZG, registered in Tamil Nadu.
The CIN (Corporate Identification Number) of Surien Pharmaceuticals is U24232TN2004PTC053031. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Surien Pharmaceuticals has 52 court cases on record: 52 filed against it. 6 are pending. Most are in the district courts.
Surien Pharmaceuticals was incorporated on 19 April 2004, making it 22+ years old. It is registered with the Registrar of Companies, Chennai.
The peers of Surien Pharmaceuticals by revenue are Leiutis Pharmaceuticals Private Limited, Salius Pharma Private Limited, Merlin Pharma Private Limited, Oasis Laboratories Pvt Ltd, Regal Healthcare Limited and 1 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Chathurappan Anbazhagan was appointed as Whole-Time Director on 11 Oct 2018. Chathurappan Anbazhagan ceased to be Additional Director on 11 Oct 2018. Ramasamy Krishnamoorthy was appointed as Managing Director on 21 Apr 2007. Surien Pharmaceuticals has 4 board changes on record in total.
Surien Pharmaceuticals can be reached through the website surienpharmaceuticals.com. Its registered office is in Chennai, Tamil Nadu, India.
The registered office of Surien Pharmaceuticals is at 108 Chekkadi Street Kovur, Chennai, Tamil Nadu, India – 602101.